Marker Therapeutics, Inc.

MRKR · Pharmaceutical Preparations

Latest available SEC filing: 10-Q ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • MRKR · 57055L206 - Common Stock, par value $0.001 per share
  • MRKR · 57055L107 - Common Stock, Par Value $0.001
Company details and SEC sources

CIK 0001094038 · SEC filing index. Filing dates describe disclosures, not live market data.

At a glance Names, identifiers, and filing context for this profile. 2 identity fields
Business address
2450 Holcombe Blvd, Tmc Partners Office 1.311, Houston, TX, 77021
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
TAPIMMUNE INC. (to 17 Oct 2018), TAPIMMUNE INC (to 29 Jun 2017), GENEMAX CORP (to 28 Jun 2007), EDUVERSE COM (to 17 Jun 2002)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .